DEPODUR Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Depodur, and when can generic versions of Depodur launch?

Depodur is a drug marketed by Pacira Pharms Inc and is included in one NDA.

The generic ingredient in DEPODUR is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Depodur

A generic version of DEPODUR was approved as morphine sulfate by HOSPIRA on September 30^th, 1992.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for DEPODUR?
What are the global sales for DEPODUR?
What is Average Wholesale Price for DEPODUR?

Summary for DEPODUR

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	24
Clinical Trials:	11
Patent Applications:	5,505
DailyMed Link:	DEPODUR at DailyMed

Drug patent expirations by year for DEPODUR

Recent Clinical Trials for DEPODUR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Columbia University	Phase 4
Washington University School of Medicine	N/A
Wake Forest University	Phase 4

See all DEPODUR clinical trials

US Patents and Regulatory Information for DEPODUR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pacira Pharms Inc	DEPODUR	morphine sulfate	INJECTABLE, LIPOSOMAL;EPIDURAL	021671-001	May 18, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pacira Pharms Inc	DEPODUR	morphine sulfate	INJECTABLE, LIPOSOMAL;EPIDURAL	021671-002	May 18, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pacira Pharms Inc	DEPODUR	morphine sulfate	INJECTABLE, LIPOSOMAL;EPIDURAL	021671-003	May 18, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for DEPODUR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pacira Pharms Inc	DEPODUR	morphine sulfate	INJECTABLE, LIPOSOMAL;EPIDURAL	021671-002	May 18, 2004	⤷ Sign Up	⤷ Sign Up
Pacira Pharms Inc	DEPODUR	morphine sulfate	INJECTABLE, LIPOSOMAL;EPIDURAL	021671-002	May 18, 2004	⤷ Sign Up	⤷ Sign Up
Pacira Pharms Inc	DEPODUR	morphine sulfate	INJECTABLE, LIPOSOMAL;EPIDURAL	021671-002	May 18, 2004	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for DEPODUR

See the table below for patents covering DEPODUR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	2004262946	METHOD FOR UTILIZING NEUTRAL LIPID TO MODIFY IN VIVO RELEASE FROM MULTIVESICULAR LIPOSOME	⤷ Sign Up
Canada	2851502	PROCEDE SERVANT A UTILISER DES LIPIDES NEUTRES AFIN DE MODIFIER LA LIBE ATION IN VIVO DEPUIS DES LIPOSOMES A VESICULES MULTIPLES (METHOD FOR UTILIZING NEUTRAL LIPIDS TO MODIFY IN VIVO RELEASE FROM MULTIVESICULAR LIPOSOMES)	⤷ Sign Up
China	1085944		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for DEPODUR

Recent Clinical Trials for DEPODUR

Make Better Decisions: Try a trial or see plans & pricing